Headcount soars at Cambridge gene editing biotechs as trials near – Boston Business Journal
Boston Business JournalHeadcount soars at Cambridge gene editing biotechs as trials nearBoston Business JournalCRISPR/Cas9 has yet to be tested in humans in the U.S., but excitement surrounding the gene editing technology has already prompted significa… Continue reading
